Astegolimab Completed Phase 2 Trials for Asthma Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT02918019 | A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma |